Beta Drugs secured Rs 117 crore from HealthQuad and other investors to expand globally and boost operational capabilities. The oncology-focused company aims to be among India's top five in the sector within five years, leveraging its strong manufacturing, R&D, and expanding export markets. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
